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Abstract
Only few small RNAs (sRNAs) have been characterized in Mycobacterium tuberculosis and their role in regulatory networks is
still poorly understood. Here we report a genome-wide characterization of sRNAs in M. tuberculosis integrating experimental
and computational analyses. Global RNA-seq analysis of exponentially growing cultures of M. tuberculosis H37Rv had
previously identified 1373 sRNA species. In the present report we show that 258 (19%) of these were also identified by
microarray expression. This set included 22 intergenic sRNAs, 84 sRNAs mapping within 59/39 UTRs, and 152 antisense
sRNAs. Analysis of promoter and terminator consensus sequences identified sigma A promoter consensus sequences for
121 sRNAs (47%), terminator consensus motifs for 22 sRNAs (8.5%), and both motifs for 35 sRNAs (14%). Additionally, 20/23
candidates were visualized by Northern blot analysis and 59 end mapping by primer extension confirmed the RNA-seq data.
We also used a computational approach utilizing functional enrichment to identify the pathways targeted by sRNA
regulation. We found that antisense sRNAs preferentially regulated transcription of membrane-bound proteins. Genes
putatively regulated by novel cis-encoded sRNAs were enriched for two-component systems and for functional pathways
involved in hydrogen transport on the membrane.
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Introduction
Regulatory RNA species can modulate transcription, trans-
lation, mRNA stability, DNA maintenance, and gene silencing.
They function through a variety of mechanisms, including changes
in RNA conformation, protein binding, base pairing with other
RNAs, and interaction with DNA [1–3]. It has been established
that small RNAs (sRNAs) are crucial elements regulating gene
expression in Gram-positive and Gram-negative bacteria [4–7].
The prototype of a bacterial sRNA is a non-coding RNA of 50–
300 nucleotides (nt) in length that acts by imperfect base pairing
with trans encoded RNA target(s). sRNAs may also be cis-encoded
and transcribe antisense (AS) to the target RNA. Recent research
has shed some light on the relevance of sRNAs in bacterial
pathogenesis, including modulation of expression of virulence
factors in response to environmental and host signals [2,8–14].
Intracellular survival of Mycobacterium tuberculosis (MTB) results
from the ability of this pathogen to sense the host environment and
to switch to a non-replicating, persistent form that is resistant to
host insult and to treatment with most antibiotics. Multiple genes
associated with persistence have been identified in MTB.
However, the complex post-transcriptional regulation underlying
the phenotypic switch to persistence remains poorly understood.
In particular, our knowledge of the regulatory networks involving
sRNAs is still in its infancy. Understanding how sRNAs control
bacterial virulence may open a new prospective in the fight against
tuberculosis (TB) and contribute to the goal of TB eradication
[15–18].
About 40 species of sRNAs have been reported so far in
mycobacteria (including MTB) by cloning approaches and
computational predictions [19,20]. Additional sRNAs have been
identified by RNA sequencing (RNA-seq) [21,22]. RNA-seq
results for sRNAs however heavily depend on threshold definition
for reads coverage and on the criteria used for transcript
annotation, thus requiring further validation [3]. Here we report
the first genome-wide expression analysis of sRNAs in MTB by
microarray followed by size determination, mapping and compu-
tational target prediction.
Results
Genome-wide Expression Profiling of sRNAs in MTB
To identify sRNAs in MTB, we performed microarray
expression analysis on small-size RNA enriched fraction extracted
from exponentially growing cultures of M. tuberculosis H37Rv. We
used a set of 1373 sRNA species previously identified by RNA-seq
(Type A candidates, [22]), which was updated to reflect changes in
annotation in the genome of MTB (type A, Table S1).
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For microarray analysis, we considered as expressed only the
candidates showing an expression mean significantly higher (p-
value ,0.05) than the positive control genes (this group included
genes expressed during exponential growth such as sigA and rrs and
the short ribosomal 5S RNA; for a complete list of control genes,
see Materials and Methods). The microarray analysis validated
258 (18.8%) species (Figure 1), about a third of which (n= 97)
showed a length below 50 nucleotides. When we calculated the
minimum free energy (MFE) associated p-value, which represents
a measure of secondary structure stability, we found that the
proportion of sRNAs showing an MFE-associated p-value ,0.05
was nearly double for ‘‘array-validated’’ candidates (37/258,
14.3%) than for the remaining ‘‘non validated’’ candidates (85/
1115, 7.6%).
Classification of MTB Putative sRNAs
A functional classification of the selected sRNAs identified was
performed based on genome location (see Materials and Methods
and Figure S1). We found 22 intergenic sRNAs, 84 candidate
sRNAs mapping within 59 or 39 UTRs, and 152 antisense sRNAs
(Table 1).
The two more represented classes identified by microarrays
were AS RNAs (60%) and 59/39 UTRs (32.6%); of the latter class,
most were 59UTRs (59UTRs: 90%). RNA species identified within
the 59 UTRs could represent cis-acting regulatory elements such as
riboswitches. Between the 59UTRs we found genes involved in cell
wall processes, intermediary metabolism, information pathways,
PE/PPE, virulence, detoxification and adaptation, and lipid
metabolism (Table S2).
Statistical Analysis of the Frequencies of Specific
Nucleotides at the 210 Region
To show that the different RNAs validated by microarray
expression analysis were transcribed, we compared the frequency
of the nucleotide’s distributions at specific positions within the210
region between sRNA candidates, annotated coding sequences
(CDSs), and random sequences. We could confirm the effective
transcription of sRNAs identified by microarrays by showing
a clear non-random distribution of nucleotides within the 210
region. In particular, we showed that our candidates show a 210
region more similar to the one of CDSs rather than to random
genomic sequences not annotated for transcripts. To achieve this
goal we used a statistical approach previously described by
Dornenburg [23]. We compared the frequency of nucleotides at
the 210 consensus hexamer between sRNA candidates, annotated
CDSs, and random sequences. The hexamer TANNNT recog-
nized by the sigma factor A was used as reference consensus. For
the set of annotated CDSs, 210 hexamers match the consensus,
on average, 1.7 times out of 3 known consensus nucleotides 210
match score). In contrast, randomly selected sequences match the
consensus only 1.5 times out of 3 (control match score) (Figure S2).
Due to the high number of terms compared for each category (see
Materials and Methods), this difference is highly significant
(P,0.0001). The 210 match score for the sRNAs is not
significantly different from that of the set of CDSs. The
comparison of Type A candidates only to the control group of
random sequences and to the consensus sequences of annotated
CDSs showed similar results. Considering microarray-validated
candidates only (score 2.0), the difference with the dataset from
CDSs increased whereas that with the random sequences slightly
decreased.
Characterization of sRNA by Northern and Identification
of the 59-end by Primer Extension
Microarray data were further validated by Northern blot
analysis. We selected 23 candidate sRNAs (Table 2) from all the
functional categories identified (see Table 1). Genomic mapping of
these sRNAs is shown in Figures S3 and S4.
The candidates chosen were:
– four intergenic (#149, 161, 224 and 1096);
– eight 59/39 UTRs of genes (#1149, 1414, 1502, 1542, 1565,
106, 189, and 193);
– ten AS (#54, 135, 1029, 540, 1080, 1556, 488, 1137, 294, and
498).
We also included candidate 1359, although it was mapped
within the Rv2165c gene, since it is highly expressed by microarray
Figure 1. Heat-map representing the expression profiles of
microarrays. As positive controls we used reference sigA, rrs and the
short ribosomal 5S RNA. Normalized control genes showed a mean
expression level of 7.1661.57. Expression level: yellow to blue (highly
expressed to lowly expressed). Statistics: red= p-value,0.05; green=p-
value .0.05.
doi:10.1371/journal.pone.0051950.g001




59/39 UTR 84 (32.6)*
AS 99 (38.4)
AS to 59/39 UTR 53 (20.5)
Total 258 (100.0)
UTR: untranslated region; AS: antisense.
*59 UTR: 51; 39 UTR: 8; both 59 and 39 UTR: 25.
doi:10.1371/journal.pone.0051950.t001
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analysis. As a negative control we used a 59UTR sRNA not
validated by microarray (#76). Since Northern blot analysis allows
relative comparison of transcript abundance, RNA was extracted
from exponential and stationary phase cultures in order to
evaluate differential expression associated with growth state. Total
RNA was extracted from the strain H37Rv. For a smaller pool
(candidates #224, 540, 1137, and 1565) we also tested the
attenuated strain H37Ra.
The results of the Northern blot showed that in most cases (20
out of 23), one or more specific bands were detected (Table 2, and
Figure 2). The Northern blot of candidate #189 showed a single
band of predicted length; in other cases (#1565) a band of the
predicted size was detected among several others. For most
candidates, however, the length observed by Northern analysis
differed from the results of the RNA-seq-based computational
mapping (for example, Figure 2, #498 and 1137). sRNAs #106,
1029 and 1414 and the negative control #76 were negative by
Northern blot analysis (data not shown). No difference was
observed between exponential and stationary phase expression for
all sRNAs cultures (Figure 2). Only candidate #224was expressed
at higher levels in M. tuberculosis H37Rv than in H37Ra.
Since computationally predicted length and that observed by
Northern blot analysis differed in almost all species, we set out to
identify the 59 ends of eight selected sRNAs (#488, 498, 1080,
1137, 1149, 1359, 1502 and 1565) by primer extension. In all
cases, we could identify one or more bands, one of which
corresponded to the predicted 59 end with +1 or 21 nt difference
(data not shown). A 210 consensus sequence for sigma factor A
(TANNNT) was identified for 7 out of 8 sRNAs mapped,
suggesting that transcription of the sRNAs is under sigA control.
Upstream of the candidate 1359 a good consensus sequence for
210 and 235 sigma B is present (NGTGG – N14–18–NNGNNG).
Identification of the 210 sigA Consensus Sequences and
Putative Terminators in sRNA Candidates
Since the 59 ends identified by primer extension well matched
those predicted by RNA-seq, the discrepancies between the length
observed by Northern blot and computational analysis might
mainly be due to inaccurate 39-end mapping. First, we performed
the analysis of all the sRNAs upstream sequences to detect the
presence of 210 consensus for sigA. We decided to search for sigA
Table 2. Validation of 23 selected candidates by Northern blot.
ID Start End Strand RNA-seq Northerna 210 Stem-loop Mapping
54 498401 498455 + 54 75 Yes AS to Rv0412cb
76d 629877 629975 + 98 Neg 59 UTR, Rv0538
106 806185 806218 + 33 Neg 39 UTR, Rv0710
135 1040645 1040938 + 293 45, 250 sigA Yes AS to Rv0932c
149 1200555 1200605 + 50 75 Intergenic
161e 1287126 1287201 + 75 180, 160 sigA Yes Intergenic
189 1453007 1453060 + 53 50 sigA Yes 39 UTR, Rv1296
193e 1476825 1476884 + 59 70, 35 39 UTR, Rvnr02 or 59 UTR, Rvnr03
224b 1735693 1735747 + 54 300, 90 Intergenic
294 2268166 2268257 + 91 70 sigA AS to 39, Rv2023A or 59, Rv2023c
488e 3557057 3557335 + 278 .300, 280, 130 sigAh Yes AS to 39 UTR, Rv3191c
498e 3597808 3598107 + 299 150 sigA Yesg AS to 39, Rv3221A or 59, Rv3221c
540 f 4025441 4025570 + 129 70 AS to 59 UTR, Rv3583c
1029 732392 732787 – 395 Neg sigA AS to Rv0636
1080e 937956 938239 – 283 230 sigA AS to 59, Rv0842
1096 1041129 1041165 – 36 300, 120, 80, 65, 60, 55 sigA Yes Intergenic
1137f 1275611 1275673 – 62 40 sigA Yes AS to 39, Rv1147
1149 1306038 1306073 – 35 80,70, 30 sigA Yes 59 UTR, Rv1174c
1359e,c 2429342 2429373 – 31 60, 30 sigB 59 UTRs, Rv2165c
1414 2641081 2641126 – 45 Neg 59 UTR, Rv2357c
1502e 3363023 3363153 – 130 100, 80, 50 sigA Yes 59 UTR, Rv3003c
1542e 3621265 3621466 – 201 280, 60 sigA 59 UTR, Rv3241c
1556e 3800005 3800091 – 86 30 sigA AS to 59, Rv3386
1565f 3837288 3837458 – 170 500, 160, 90, 60 sigA Yes 59 UTR, Rv3418c
aLength of the principal bands visualized by Northern blot analysis.
bThe presence of a 210 sigA consensus sequence about thirty-eight nucleotides upstream of the predicted 59end suggests that the sRNAs length is in accordance with
the band observed by Northern blot.
cType C candidate.
dNegative control.
eNorthern blot tested in M. tuberculosis H37Rv, exponential and stationary growth phases.
fNorthern blot tested in M. tuberculosis H37Rv and M. tuberculosis H37Ra (exponential growth phase).
gconsidering 39-end mapping according to Northern blot results (175 nucleotides downstream the predicted 39-end).
hconsidering the 59-end mapping according to the 59-end primer extension.
doi:10.1371/journal.pone.0051950.t002
Small RNAs in M. tuberculosis
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Figure 2. Northern blot results for selected candidates. The RNAs were extracted as indicated in M&M: exp: M. tuberculosis H37Rv in
exponential growth phase; stat: M. tuberculosis H37Rv in stationary growth phase; Rv: M. tuberculosis H37Rv; Ra: M. tuberculosis H37Ra. Arrows
indicate the predicted length.
doi:10.1371/journal.pone.0051950.g002
Small RNAs in M. tuberculosis
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consensus motifs because this is the primary sigma factor that
regulates gene expression during the exponential growth phase.
We searched for 210 sigma A consensus sequences (TANNNT)
within 250 and +15 nucleotides from the 59-end mapped
according to RNA-seq results. At the same time, we searched
for putative terminators downstream of the predicted sRNAs. The
39-end region (220/+270 nucleotides) was sought for intrinsic
terminators using the GeSTer algorithm [24], and for rho-
independent terminators, according to Gardner et al. [25]. In
60.5% of cases we detected a sigA promoter consensus sequence
upstream of the presumed 59-end. Terminator consensus motifs
were present in 22.1% of the regions downstream of the sRNA.
Only a minor percentage (13.6%) of sRNAs presented both
promoter and terminator sequences, whereas one third (31.0%) of
predicted candidates did not show consensus motifs either for
sigma A promoters or terminators (Table 3).
Classification of all 1373 candidates, promoter and terminator
consensus sequence analyses, and genomic annotation are
summarized in Table S1.
In silico Identification of Pathways Regulated by
Antisense sRNAs
An important question in sRNA biology is to identify the genes
that these molecules regulate. We performed an in silico analysis to
identify pathways regulated by the set of novel sRNAs discovered
in MTB. We focused on AS RNAs because the direct targets for
this class of sRNAs are known. When we performed microarray
analysis we found 152 AS sRNAs that overlap the same number of
unique target genes in the opposite strand (Table 1). Using
functional enrichment analysis, we identified molecular functions
and pathways enriched in AS-regulated genes in MTB. In
particular, hydrogen transport on the membrane (GO:0015078,
GO:0015077, GO:0006818, GO:0015992, GO:0034220) and
two-component systems (mtu02020) emerged as function poten-
tially subjected to antisense regulation. When we analyzed cellular
location, we found that membrane-bound proteins were prefer-
entially targeted (GO:0044425, GO:0005886, GO:0031224).
These results are summarized in Table 4. The corresponding
targeted genes can be found Table S3.
Discussion
Here we report on the integration of experimental and
computational methods to identify 258 novel antisense and
intergenic sRNAs in MTB. The present work derives from
a previous, genome-wide identification of candidate sRNAs by
RNA-seq [22]. Large RNA-seq dataset require accurate valida-
tion, especially for genome annotation of novel transcripts. We
considered reliable the sRNAs identified with high reads coverage
and validated these sRNAs by microarray and, for representative
species of the microarray-validated pool, by Northern blot and
primer extension analyses. This approach provided more details
on the annotation of the candidates; indeed, the particular design
strategy we adopted for microarray probes allowed acquiring
important data on the size of the sRNAs. The inclusion of probes
targeting well-known control genes permitted the collection of
expression data for these newly discovered sRNAs.
Our results lead to several conclusions. As supported by 210
region and 59 end mapping analyses, our computational approach
applied to Illumina sequencing results provided reliable detection
of sRNA transcripts. All but one of the sRNAs mapped
experimentally are preceded by a sigA promoter consensus
sequence. In addition, an initial analysis of sRNA target pathways
indicated that AS sRNAs preferentially target genes involved in
two-component systems and membrane activity. Our results
suggest that expression of the sRNAs described may be not as
part of the stress response, but are actively involved in the
regulation of basic metabolism in MTB.
Together, our study provides a comprehensive top-down
demonstration of methods whereby large sets of RNA-seq data
on sRNAs can lead to detailed sRNA mapping and identification
of target pathways. Our analytical path differs from previous
studies on sRNAs of M. tuberculosis, which reported only few
sRNAs and did not provide a prediction of putatively regulated
pathways. Indeed, despite Arnvig and colleagues performed RNA-
seq to identify novel sRNAs in MTB [21], they provided an
overview on genome-wide data and focused their attention
characterizing only few of the sRNAs detected. In the present
report we further characterized several candidates previously
identified by us (e.g. #84, #1169, #1137, #488) [22] and by
Arnvig and colleagues (MTS0479, MTS0997, MTS0903,
MTS2458, respectively) [21]. Our work provides more compre-
hensive data on recently discovered sRNAs in MTB and statistics
analysis support our experimental data: in fact, the genomic
regions where we mapped sRNA candidates showed consensus
sequences for active transcription indicating the probability to be
transcribed.
Our starting dataset included a high number of candidates
(.1000) as reported by other studies based on RNA-seq approach
[26]. By microarray expression profiling, we validated nearly 20%
of the previously identified putative sRNAs. These sRNA species
showed to be enriched in higher secondary structure stability, as
supported by MFE analysis. We found ,100 sRNAs shorter than
50 nucleotides. sRNAs are usually between 50 and 200 nt in
length; however, smaller RNAs of the size of microRNAs have
been described in bacteria [23,27]. The functional significance of
these bacterial microRNAs remains to be elucidated.
Most of the sRNAs identified are antisense. This is in agreement
with recent findings that extensive antisense transcription occurs in
bacteria, as it does in Eukarya and in Archaea [14,23,28–31]. The
target gene for AS sRNAs is likely to be the antisense CDS, whose
expression is negatively controlled either by interfering with
transcription/translation or by favoring mRNA degradation. The
analysis of pathways regulated by AS sRNAs identified enrichment
for two-component systems and cell-wall components. This
preliminary finding suggests that cis-acting RNAs may inhibit
stress-responsive modules, such as the two-component systems
[32–34], and they may also affect other critical functions such as
the metabolism of the cell wall, which is a virulence determinant of
the tubercle bacillus [35–37].
Table 3. Promoter and terminator consensus sequences
found among 258 M. tuberculosis sRNAs by bioinformatics
approach.
Consensus n (strand+; strand–) %
promoter POS; terminator POS 35 (6; 29) 13.6
promoter POS; terminator NEG 121 (60; 61) 46.9
promoter NEG; terminator POS 22 (8; 14) 8.5
promoter NEG; terminator NEG 80 (42; 38) 31.0
Total 258 (116; 142) 100.0
Sequence inspection of the 250/+15 region at the predicted 59end for sigA
consensus sequences and of the region 220/+200 at the 39 end for termination
signals. Presence (POS); Absence (NEG).
doi:10.1371/journal.pone.0051950.t003
Small RNAs in M. tuberculosis
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We have hypothesized a possible function for some of the 59/39
UTR sRNAs validated by Northern blot. Some of our sRNAs
have a role in transcription attenuation: candidate 1502, upstream
of gene ilvB (Figure S4), coincides with the previously described
mcr9-mpr14 [20]. However, while DiChiara et al. detected this
sRNA only in Mycobacterium bovis BCG, we detected mcr9-mpr14 in
MTB H37Rv. Since the ilvB gene is part of the isoleucine-valine
operon, the presence of the short peptide encoded by the
candidate 1502 (with its typical structure ‘‘3 valine, 1 isoleucine’’)
suggests that also in mycobacteria, as in most bacteria investigated
so far [38], this sRNA is part of an attenuator system for
controlling valine-isoleucine synthesis. In order to confirm the
existence of attenuation in mycobacteria, we analyzed the sRNA
candidate that was mapped upstream of leuA. This candidate
(#1938; see Table S1) was classified among class C sRNAs [22]
and was not included in our initial selection. By sequence analysis
we found a 13 amino acids long coding region, containing a stretch
of 3 consecutive leucine codons, and followed by a stem-loop
structure suggesting a possible role in the control of leuA
expression. The identification by Northern analysis of multiple
bands at 85, 65 and 45 nt, respectively (Figure S5) is in good
agreement with an attenuator role of this candidate. Interestingly,
this sRNAs is the only species tested in this work that showed
differential relative signal intensity between virulent and avirulent
M. tuberculosis strains (Figure S5), suggesting a different control of
this biosynthetic pathway in these two mycobacteria.
Our work suggests the identification of alternative RNA-based
regulatory tools such as riboswitches within the 59-end of mRNAs.
Riboswitches are part of the mRNA molecule they regulate,
usually the 59UTR, and hence act in cis. They can adopt different
conformations in response to environmental signals, including
stalled ribosomes, uncharged tRNAs, elevated temperatures, or
small molecule ligands [39]. Thus, riboswitches include the above-
mentioned attenuators. In accordance with the findings of Arnvig
et al. [21], our data suggest that in MTB this kind of regulation is
rather widespread, as it was found in other Gram-positive bacteria
like B. subtilis [40,41].
Arnvig and colleagues used the reads-coverage ratio between
the 59 UTR and the downstream CDS to better identify putative
riboswitches [21]. We performed RNA-seq only on the small-size
RNA fraction, therefore the comparison of reads-coverage
between candidates and CDSs could not be performed. However,
by combining our experimental observations and computational
analysis we could detect some putative riboswitches.
Indeed, our data suggest that candidate 1149 might be co-
transcribed with TB8.4 and could act as a riboswitch, regulating
TB8.4 expression, encoding a low molecular weight T-cell antigen
[42] The candidate 1096 could also be a riboswitch regulating
pstS2, one of the three components of the inorganic phosphate
Table 4. Functional enrichment of cis-regulated genes.
Term Description N Genes p-value
GO:0006796 phosphate metabolic process 7 0.0066
GO:0015078 hydrogen ion transmembrane transporter activity 4 0.0097
GO:0043284 biopolymer biosynthetic process 13 0.0117
GO:0019538 protein metabolic process 15 0.014
GO:0044271 nitrogen compound biosynthetic process 2 0.0153
GO:0006793 phosphorus metabolic process 7 0.0156
GO:0044425 membrane part 26 0.0178
GO:0015077 monovalent inorganic cation transmembrane transporter activity 4 0.0187
GO:0005886 plasma membrane 16 0.0194
GO:0046933 hydrogen ion transporting ATP synthase activity, rotational mechanism 3 0.0208
GO:0031224 intrinsic to membrane 25 0.022
GO:0045259 proton-transporting ATP synthase complex 3 0.0266
GO:0016020 Membrane 27 0.0308
GO:0006818 hydrogen transport 3 0.0335
GO:0015992 proton transport 3 0.0341
GO:0016310 Phosphorylation 6 0.037
GO:0044267 cellular protein metabolic process 11 0.0389
GO:0051171 regulation of nitrogen compound metabolic process 4 0.0405
GO:0015986 ATP synthesis coupled proton transport 3 0.0442
GO:0016469 proton-transporting two-sector ATPase complex 3 0.0442
GO:0015985 energy coupled proton transport, down electrochemical gradient 3 0.0449
GO:0010556 regulation of macromolecule biosynthetic process 4 0.0457
GO:0034220 ion trans-membrane transport 3 0.0491
mtu02020 two-component system 6 0.0363
mtu00230 purine metabolism 6 0.0732
Functional annotation of M. tuberculosis genes was obtained from different databases; Fisher’s exact test, P,0.05 (see Methods).
GO: gene ontology; mtu: KEGG pathway.
doi:10.1371/journal.pone.0051950.t004
Small RNAs in M. tuberculosis
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detection component of the membrane-associated phosphate-
specific transporter (Pst) [43,44]. pstS2 knockout strains showed
attenuated virulence [44]. Moreover, pstS2 and pknD genes are
encoded within the same operon, and pknD knockout strains do
not survive in inorganic phosphate poor-growing conditions [43].
Thus, candidate 1096 may have a crucial sensing role in
controlling the pstS2-pknD operon. Interestingly, the candidate
135 mapped antisense to the 59 region of the pstS2 gene (Figure
S3). Thus, the operon encoding for this gene seems to be under
tight control.
Other putative riboswitches we have identified are candidate
161, controlling expression of a nitrate reductase (narGHJI operon)
[45,46] (Figure S3) and candidate 1565, mapping within the
59UTR of groES, encoding for a co-chaperonin protein [47].
Arnvig and colleagues [21] identified the expression profile for the
59 UTR associated with the groES gene. We suggest that this sRNA
may be a thermosensor, as frequently found in other bacteria
upstream of genes with a function similar to groES.
Several predicted intergenic sRNAs have been confirmed by
Northern analysis (149, 161, 224 and 1096 in Table 2). A more
careful analysis of other sRNAs indicated that some of them were
likely to be also intergenic. This is the case for candidate 1359.
Looking at the annotated sequence we observed that this sRNA
maps within Rv2165c (mraW, S-adenosyl-methyltransferase). How-
ever, by comparing the polypeptide encoded by MTB with the
protein encoded by M. bovis BCG we found that homology starts
53 amino acids downstream of the indicated start codon, where
a GTG codon is present (nucleotide 2429447) preceded by a Shine-
Dalgarno sequence (GGGGAGG) (Figure S6). Thus, candidate
1359 is transcribed upstream of Rv2165c, in the intergenic region.
Candidate 488, previously reported by Arnvig et al. (MTS2458;
[21]), and originally classified in this work as antisense to 39UTR
of Rv3191c, may be intergenic since it was not overlapped to the
39end of the Rv3191c, as supported by the length of the transcript
visualized on Northern blot.
Candidate 498 is transcribed in opposite direction to both
neighboring genes TB7.3 and Rv3321A. Its predicted length
(300 nt) classified this sRNA as a 39UTR to Rv3321A. However,
the length observed by Northern blot, the presence of both a sigma
A consensus sequence and a possible stem-loop structure support
the hypothesis that the candidate 498 is a trans-acting sRNA,
whose targets have to be identified, rather than a sRNA over-
lapping to the Rv3321A-39 end.
Candidate 190 mapped upstream of 16S rRNA gene being
entirely contained in mcr3 sRNA gene [20]. Interestingly, upstream
of the 59 end of mcr3 no promoter consensus sequences were
present. On the contrary, upstream of the 59end of 190, which is
internal to mcr3, we found 210 and 235 sigA consensus
sequences, that can be identified with the most active rRNA
operon promoter, P3 [48–50]. Thus sRNAs such as 190, 191, and
192 mapping in the ribosomal DNA could be cis-acting regulatory
elements controlling unique MTB rRNA operon.
The candidate 193 (predicted length: 60 nucleotides) mapped
between the ribosomal RNAs 23S and 5S (rrl and rrf genes,
respectively). According to the positive signal obtained by
Northern blot, this putative sRNA might be a residual RNA
derived from ribosomal RNA processing. Additional bands at
higher and lower molecular weight observed by Northern blot
support this hypothesis. Very recently, ribosomal noncoding
RNAs have been described in eukaryotic cells [51]. Despite
similar mechanisms have not been described in bacteria, further
experiments are needed to confirm the small RNA nature of this
candidate originating by the ribosomal genomic region.
Overall, our data greatly increase the complexity of sRNA
complement in MTB and suggest that RNA-mediated regulation
in this organism may be as common and multifaceted as in other
bacteria [3,52]. Furthermore, we detected several new sRNAs and
riboswitch-like regulators, which provide new insights into the
dynamic regulation of gene expression in MTB. Indeed,
riboswitches represent a cost-effective means for genetic regulation




RNA extraction. For analysis of sRNAs, M. tuberculosis
H37Rv was grown in Middlebrook 7H9 medium supplemented
with 10% OADC (Oleic Acid, Albumin, Dextrose, Catalase).
Exponential growth phase culture was harvested at OD600
between 0.5 and 0.8 and washed twice in PBS. The small-size
RNA (approx. ,200 nucleotides) enriched fraction was extracted
using the mirVanaTM miRNA Isolation Kit (Ambion, Austin, TX,
USA) according to manufacturer’s instruction. Both small-size
RNA enriched and total RNA (depleted sRNAs) fractions were
collected and analysed with Agilent 2100 Bioanalyzer (Agilent
Biotechnologies, Santa Clara, CA, USA).
Candidate sRNAs, Promoter and Terminator Consensus
Sequences
A custom analysis pipeline was developed for analyzing Illumina
reads (details are reported in Pellin et al. [22]): after computational
processing of reads to remove the poly-A tail, reads have been
mapped to the whole genome using SOAPv1 tool, and those
regions coding for proteins or for functional RNA molecules
(tRNAs and rRNAs) were excluded from the analysis. To identify
putative loci encoding for sRNAs a coverage map and a conser-
vation map were superimposed. Coverage value of a specific
genome base derives from RNA-seq data and corresponds to the
count of reads overlapping that specific position. The calculation
of the conservation value is based on the analysis of a BLASTN 2.0
output file, regarding the pairwise alignment of each MTB
intergenic sequences and a database containing all intergenic
sequences extracted from all the others genomes in the MTB
genus. The conservation value then corresponds to the weighted
count of genomes within the MTB genus, with at least one
pairwise alignment hit that satisfies high quality criteria.
To identify sRNA candidates the following criteria were
considered:
1- region coverage by consecutive nucleotides;
2- region length $30 and #550 nucleotides.
And at least one of the following conditions must be satisfied:
3.1 RNA-seq coverage value $50 or,
3.2 Genomic region conservation value $1.77 or,
3.3 RNA-seq coverage value $22 and genomic region
conservation value $0.97.
Coverage and conservation thresholds were established on the
empirical distribution functions and determined by means of
statistical criteria according to data characteristics.
In order to assess candidates’ reliability, many different
characteristics of each putative sRNA were analyzed. In particular,
Minimum Folding Energy (MFE) and relative p-value (MFE p-
value) were taken into account.
The application of such pipeline (fully described in [22]) to our
data resulted in the identification of 1948 sRNA candidates,
classified as Type A (based on criteria 1, 2 and 3.1; 1378
candidates), Type B (based on criteria 1,2 and 3.3; 114 candidates)
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and Type C (based on criteria 1,2 and 3.2; 456 candidates). In this
work we focused on Type A candidates only. In fact, we would
expect that the most promising candidates are included in this
category, whereas Type B and Type C could include higher
number of false positives due to the criteria used for their
identification.
For the present work, an update on the annotation of the
candidates has been performed in January 2012 to include in the
genome most recently annotated CDSs [53]. In particular, the
analysis published in Pellin et al. [22] was performed using as
reference the NC_000962.gff database; whereas for the update the
NC_000962.2.gff database was used. Candidates obtained by
RNA-seq were further analyzed for the presence of promoter and/
or terminator consensus sequences. For the analysis of the
promoter region we used the consensus sequences described by
Sachdeva and coworkers [54]. In particular, we analyzed the
region between 250 and +15 nucleotides from the predicted 59-
end of the candidates for the presence of a Sigma A (sigA) 210
consensus motif (mismatch: 0). In particular, we analyzed the
region between 250 and +15 nucleotides from the predicted 59-
end of the candidates for the presence of a Sigma A (sigA) 210
consensus motif TANNNT (with allow mismatch equal to 0) by
means of a custom script written in R and using BioConductor
package Biostrings [55].
In order to identify putative terminators, we applied both
GeSter and RNIE algorithm.
Gester analysis was performed by means of the web based
version called WebGester [56] with parameters set to default.
Results reported in this paper regards to putative terminators
satisfying DG cut-off equal to 216.98.
The RNIE algorithm was run in the ‘‘gene mode’’ that is
optimized to individually annotate the downstream regions of
genes or, more generally, putative encoding regions. We followed
the same pipeline suggested by RNIE authors in [25]. Initially we
took all the annotated coding sequences from the MTB complete
genome and extracted subsequences from 220 to +80 nt around
all annotated gene termini, according to available annotation file.
Each of these was folded using the RNAfold routine from the
Vienna package [57] and then subjected to a permutation test
where native MFEs were compared to the pooled distribution of
MFEs for 1000 permuted sequences with the same dinucleotide
content in each termini. The regions that had a P,0.001 where
subsequently fed into the alignment and folding algorithm
Cmfinder [58]. The three most significant covariance model
obtained from MTB CDS and TRIT model proposed in [25] were
deployed to annotate the downstream regions of putative
candidates.
Microarray for sRNA Candidates Expression
CombiMatrix microarray technology (Irvine, CA, USA) has
been adopted to validate putative sRNA candidates by expression
evidence. Probe sets for candidates have been designed according
to the following criteria: the probes were non-overlapping
sequences of 30 nt, spanning all the candidate length. Probes
were located at least 5 nt from each other and from the candidate
boundaries. As result, probe sets were made of one single probe
when candidates were shorter than 75 nt of length; two probes
when candidates length were between 75 and 110 nt; three probes
when candidates length were between 110 and 180 nt, and four
probes for longer candidates. To each probe, a control mismatch
probe was provided (mismatch: two bases). As positive controls,
probes targeting the following genes have been included: sigA
(Rv2703), 16S (rrs, Rvnr01), and 5S (rrf, Rvnr03). As negative
controls we considered the same number of probes of the positive
controls, made of random sequences not mapping in the M.
tuberculosis H37Rv genome. Each array contained two complete
probe sets and relative mismatches, each in duplicate. Small-size
RNA fraction and total RNA fraction depleted of small-size RNAs
were prepared using mirVana miRNA Isolation kit (Applied
Biosystems/Ambion, Austin, TX, USA). The ULS labeling kit for
CombiMatrix arrays (Kreatech Biotechnology BV, Amsterdam,
The Netherlands) was used to label RNA samples with biotin and
for hybridization on a 12K array followed by electrochemical
detection on the ElectraSense reader performed according to
manufacturer’s instructions. Two independent experiments were
carried out starting from two biological replicates each (M.
tuberculosis H37Rv grown in Middlebrook 7H9 10% OADC,
OD600 between 0.5 and 0.8). Microarray hybridization was
carried out twice (technical replicate) for each biological replicate;
every microarray was acquired at least twice. Results were
analyzed applying Robust Multichip Analysis (RMA) procedure
on the logarithm of the background (mismatches) corrected perfect
match electrical current intensities.
We compared the candidates expression with controls by means
of a t-type statistic test. P-values were computed by means of
permutations, to avoid any distributional assumption, and adjusted
for multiplicity by means of the Holm-Bonferroni method [59,60].
Candidates showing an expression mean significantly higher than
the expression of controls (p-value ,0.05) were considered as
validated. Then, a combined p-value (namely p-adj) for each
candidate was calculated with Fisher rule considering both RNA-
seq and microarray results.
Criteria for the Classification of sRNAs
We decided to consider approximately 60 nucleotides at the 59
end of a gene as putative promoter region. As reported by
Gardner and colleagues [25], the majority of termination signals
are within 80 nucleotides from the 39-end of a gene. Thus, we have
considered as intergenic those sRNAs mapping more than 80 nt
upstream or downstream of a neighboring CDSs. Candidates
mapping within #80 nucleotides from a CDS on the same strand
were considered potentially synthesized as untranslated regions
(59/39 UTRs). Candidates synthesized by the strand opposite to
a CDS or a UTR are antisense (AS) sRNAs, and can be divided in
subclasses depending on their relative position.
Northern Blot Analysis
10 mg of total RNA were separated on a 6% denaturing
polyacrilamyde gel, blotted on a positively charged membrane
(Hybond N+, GE Life Sciences), and hybridized to specific 32P-
labeled riboprobes or oligonucleotides, as described previously
[61]. Membranes were exposed to a phosphor screen and
visualized with a phosphorimager. The oligonucleotides used are
reported in Table S4 and Table S5, respectively.
Primer Extension Analysis
The oligonucleotide probes were 59 end labeled with T4
polynucleotide kinase (Promega). 59 ends were identified by primer
extension analysis, as described in Boorstein and Craig [62]: an
annealing mix (10 ml), containing 10 mg of total RNA, 1 U/ml
RNasin (Promega), 0.5 pmole radiolabeled oligo and 1X ss-
hybridization buffer (300 mM NaCl, 10 mM Tris HCl pH 7.5,
2 mM EDTA), was denatured at 80uC for 4 minutes and
incubated for 2 hours at 50uC for the annealing. Then, to the
annealing mix were added 40 ml of 1.25 X RT-buffer (1.25 mM of
each dNTP, 12.5 mM DTT, 12.5 mM Tris HCl pH 8, 7.5 mM
MgCl2), 5 U RNasin (Promega) and 10 U AMV Reverse
Transcriptase (Finnzymes) and incubated 30 min at 50uC for the
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extension. RNA was hydrolyzed with NaOH and all samples were
neutralized with HCl and then precipitated and dissolved in 6 ml
stop mix (95% formamide, 20 mM EDTA, 0.05% bromophenol
blue, 0.05% xylene cyanol FF). Reaction products were separated
on a 6% denaturing polyacrylamide gel along with sequencing
reactions made with the same labeled oligonucleotides used for the
primer extensions.
Statistical Analysis of the 210 Region
We used a statistical approach to further validate sRNA
candidates. The approach described by Dornenburg [23] was
adapted for this scope.
In summary, we compared the frequency of specific nucleotides
at fixed positions within the210 consensus region. Due to the lack
of consistent published data on 210 consensus sequences in MTB,
we considered only the TANNNT hexamer recognized by the
sigma factor sigA. Therefore, we analyzed the frequency of T in
position 213, A in position 212 and T in position 28 for our
sRNA candidates, for annotated CDSs in the genome of MTB and
for a set random sequences, all of the same sample size. Random
sequences were generated and used as control. A score of 3 was
attributed when all the 3 nucleotides TAT were found at the
expected position (213, 212, 28, respectively); a score of 2, 1 or
0 was attributed when 2, 1 or 0 nucleotides, respectively were
found at expected positions. An average of the scores was then
calculated for each of the three categories (candidates, annotated
CDSs and control sequences). A Mann-Whitney test statistic was
used to compare scores and p-values computed by permutation
methods. For comparison we considered a number of random
sequences equal to the sample size considered by the permutation.
Sample sizes were as follow: 1948 candidates (all), 1373 type A
candidates, 260 validated candidates, 4048 CDSs. All statistical
analyses were performed in R and Bioconductor environment
[55].
Functional Enrichment of Antisense Regulated Genes
We obtained functional annotation for MTB genes from three
different sources: (i) GO terms from the DAVID database [63], (ii)
metabolic pathways from the KEGG database [64], and (iii)
functional categories from the TubercuList database (http://
genolist.pasteur.fr/TubercuList). We then applied the Fisher’s
Exact Test to determine biological terms that are enriched among
antisense-regulated genes, based on the contingency table shown
in Table S6. The test was slightly modified by removing one gene
from the list of interest (i.e. a-1) before computing the Fisher exact
probability; this modification removes the effect of terms based on
single genes only [65].
Supporting Information
Figure S1 Schematic representation of sRNA candidates
classification according to their mapping position. Thick
black arrows indicate coding sequences (CDS); thin arrows
indicate sRNAs; dotted arrows the distance from the 59/39 ends
of CDS to the putative 59/39end of the sRNA; AS: antisense.
(TIF)
Figure S2 Schematic representation of the distance
between the 210 consensus hexamer in candidate
sRNAs, annotated coding region and random sequences.
Picture of the relative mean score differences among sequences
groups. To preserve as best as possible these dissimilarity, we
obtained the plot coordinates from a non-linear multidimensional
scaling of the pairwise absolute differences, taken as inter-groups
distance matrix.
(TIF)
Figure S3 Schematic representation of the mapping
position of sRNA candidates validated by Northern blot
(from 54 to 1029). Empty arrows represent coding sequences
(CDS), whereas sRNA candidates are reported as grey arrows.
Dotted arrow (candidate 1359) represents the possibly erroneous
annotation of the CDS Rv2165c. Dotted lines represent UTRs.
(TIF)
Figure S4 Schematic representation of the mapping
position of sRNA candidates validated by Northern blot
(from 1080 to 1565).
(TIF)
Figure S5 Northern blot for candidate 1938 in M.
tuberculosis H37Rv and H37Ra (exponential growth
phase).
(TIF)
Figure S6 Schematic representation for the mapping
position of the sRNA 1359 validated by Northern blot.
(TIF)
Table S1 Dataset including all the candidates (A, B, C
types) representing the starting point of the present
work.
(XLSX)
Table S2 Functional categories of genes showing RNA
species within the 59 UTR. Classification was performed
according to TubercuList.
(XLSX)
Table S3 Functional enrichment of cis-regulated genes.
(XLS)
Table S4 List of oligonucleotides used in the Northern
blot. * Oligo: 32P-labelled oligonucleotides used as probes in the
Northern blot assays; FWD or REV: primers used to amplify the
genomic regions to be used as templates in the in vitro transcription
of the riboprobes.
(XLSX)
Table S5 List of other oligonucleotides used for the
primer extension. DAVID database and TubercuList have
been used for functional annotation of MTB genes. GO: gene
onthology; mtu: KEGG pathway. TBL: TubercuList.
(XLSX)
Table S6 Contingency table for evaluating functional
enrichment of antisense-regulated genes. a = number of
AS-regulated genes annotated with term j; b = number of AS-
regulated genes not annotated with term j. The quantities c, and
d are similarly defined for the remaining genes not overlapped by
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